The serum concentration of infliximab in cases of autologous blood donation for patients with rheumatoid arthritis

Modern Rheumatology

Volumn 17, Issue 1, 2007, Pages 24-27

  Mochizuki, Takeshi ^a   Momohara, Shigeki ^a   Ikari, Katsunori ^a   Okamoto, Hiroshi ^a   Kobayashi, Shu ^a   Tsukahara, So ^a   Iwamoto, Takuji ^a   Kawamura, Koichiro ^a   Saito, Seiji ^a   Tomatsu, Taisuke ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Autologous blood donation; Infliximab; Orthopaedic surgery; Rheumatoid arthritis; Total knee replacement

Indexed keywords

INFLIXIMAB; METHOTREXATE; ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD SAMPLING; CLINICAL ARTICLE; DRUG BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TOTAL KNEE REPLACEMENT; EVALUATION; KNEE ARTHROPLASTY; MIDDLE AGED; RISK FACTOR;

AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD TRANSFUSION, AUTOLOGOUS; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 34247612482     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-006-0539-6     Document Type: Article

References (15)

1. R Anderson 1996 The orthopedic management of rheumatoid arthritis Arthritis Care Res 9 23-8
2. J Etchason L Petz E Keeler L Calhoun S Kleinman C Snider 1995 The cost effectiveness of preoperative autologous blood donations N Engl J Med 332 719-24 7854380 10.1056/NEJM199503163321106 1:STN:280:ByqC2MjlvFY%3D
3. J Ledingham C Deighton British Society for Rheumatology Standards Guidelines and Audit Working Group 2005 Update on the British Society for Rheumatology guidelines for prescribing TNFalpha blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001) Rheumatology (Oxf) 44 157-63 10.1093/rheumatology/keh464 1:STN:280:DC%2BD2M%2FlsVSksA%3D%3D
4. RN Maini FC Breedveld JR Kalden JS Smolen D Davis JD Macfarlane 1998 Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor α monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis Arthritis Rheum 41 1552-63 9751087 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W 1:CAS:528:DyaK1cXmsVChtbg%3D
5. PA Rosandich JT Kelley 3rd DL Conn 2004 Perioperative management of patients with rheumatoid arthritis in the era of biologic response modifiers Curr Opin Rheumatol 16 192-8 15103244 10.1097/ 00002281-200405000-00005 1:CAS:528:DC%2BD2cXksFGksb4%3D
6. DP Mooney M O'Reilly RL Gamelli 1990 Tumor necrosis factor and wound healing Ann Surg 211 124-9 2301991 10.1097/00000658-199002000-00002 1:STN:280:By%2BC2cnltVc%3D
7. L Marchal G D'Haens G Van Assche S Vermeire M Noman M Ferrante 2004 The risk of post-operative complications associated with infliximab therapy for Crohn's disease: A controlled cohort study Aliment Pharmacol Ther 19 749-54 15043515 10.1111/j.1365-2036.2004.01904.x 1:CAS:528:DC%2BD2cXktVGnu7Y%3D
8. JF Colombel EV Loftus Jr WJ Tremaine JH Pemberton BG Wolff T Young-Fadok 2004 Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy Am J Gastroenterol 99 878-83 15128354 10.1111/ j.1572-0241.2004.04148.x 1:CAS:528:DC%2BD2cXlt1Cjur4%3D
9. JT Giles SJ Bartlett AC Gelber S Nanda K Fontaine V Ruffing 2006 Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis Arthritis Rheum 15 55 333-7 10.1002/art.21841
10. SC Talwalkar DM Grennan J Gray P Johnson MJ Hayton 2005 Tumour necrosis factor alpha antagonists and early postoperative complications in patients with inflammatory joint disease undergoing elective orthopaedic surgery Ann Rheum Dis 64 650-1 15769927 10.1136/ard.2004.028365 1:STN:280:DC%2BD2M7jslGgsQ%3D%3D
11. D Wendling JC Balblanc A Brousse A Lohse G Lehuede P Garbuio 2005 Surgery in patients receiving anti-tumour necrosis factor alpha treatment in rheumatoid arthritis: An observational study on 50 surgical procedures Ann Rheum Dis 64 1378-9 16100348 10.1136/ard.2005.037762 1:STN:280:DC%2BD2MvjtFKnsw%3D%3D
12. C Bibbo JW Goldberg 2004 Infectious and healing complications after elective orthopaedic foot and ankle surgery during tumor necrosis factor-alpha inhibition therapy Foot Ankle Int 25 331-5 15134615
13. K Nishimura N Wakimoto J Sasahara C Yanagisawa F Eda J Nishino 2005 No change of infliximab levels in stored blood for preoperative autologous blood donation: A preliminary report Mod Rheumatol 15 302-4 17029083 10.1007/s10165-005-0404-z
14. SA Siegel DJ Shealy MT Nakada J Le DS Woulfe L Probert 1995 The mouse/ human chimeric monoclonal antibody cA2 neutralizes TNF in vitro and protects transgenic mice from cachexia and TNF lethality in vivo Cytokine 7 15-25 7538333 10.1006/cyto.1995.1003 1:CAS:528:DyaK2MXjs1ehtL0%3D
15. BJ Scallon MA Moore H Trinh DM Knight J Ghrayeb 1995 Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions Cytokine 7 251-9 7640345 10.1006/cyto.1995.0029 1:CAS:528:DyaK2MXls1ait70%3D